Description
Dengue Virus 2 Envelope Protein (DENV)
| Catalog number: | B2015064 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 10 ug |
| Molecular Weight or Concentration: | 13.8 kDa |
| Supplied as: | Solution |
| Applications: | molecular tool for various biochemical applications |
| Storage: | -20 C |
| Keywords: | Dengue Virus 2 Envelope Protein (DENV) |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Abd Wahab NZ, Ibrahim N. Styrylpyrone Derivative (SPD) Extracted from Goniothalamus umbrosus Binds to Dengue Virus Serotype-2 Envelope Protein and Inhibits Early Stage of Virus Replication Molecules. 2022 Jul 18;27(14):4566.
- Kudlacek ST, Metz S, Thiono D, Payne AM, Phan TTN, Tian S, Forsberg LJ, Maguire J, Seim I, Zhang S, Tripathy A, Harrison J, Nicely NI, Soman S, McCracken MK, Gromowski GD, Jarman RG, Premkumar L, de Silva AM, Kuhlman B. Designed, highly expressing, thermostable dengue virus 2 envelope protein dimers elicit quaternary epitope antibodies Sci Adv. 2021 Oct 15;7(42):eabg4084.
- Dubey KD, Tiwari G, Ojha RP. Targeting domain-III hinging of dengue envelope (DENV-2) protein by MD simulations, docking and free energy calculations J Mol Model. 2017 Apr;23(4):102.
- Chotiwan N, Roehrig JT, Schlesinger JJ, Blair CD, Huang CY. Molecular determinants of dengue virus 2 envelope protein important for virus entry in FcRIIA-mediated antibody-dependent enhancement of infection Virology. 2014 May;456-457:238-46.
- Srisutthisamphan K, Jirakanwisal K, Ramphan S, Tongluan N, Kuadkitkan A, Smith DR. Hsp90 interacts with multiple dengue virus 2 proteins Sci Rep. 2018 Mar 9;8(1):4308.
- Mani S, Tripathi L, Raut R, Tyagi P, Arora U, Barman T, Sood R, Galav A, Wahala W, de Silva A, Swaminathan S, Khanna N. Pichia pastoris-expressed dengue 2 envelope forms virus-like particles without pre-membrane protein and induces high titer neutralizing antibodies PLoS One. 2013 May 23;8(5):e64595.
- Gandham SH, Volk DE, Lokesh GL, Neerathilingam M, Gorenstein DG. Thioaptamers targeting dengue virus type-2 envelope protein domain III Biochem Biophys Res Commun. 2014 Oct 24;453(3):309-15.
- Wadood A, Mehmood A, Khan H, Ilyas M, Ahmad A, Alarjah M, Abu-Izneid T. Epitopes based drug design for dengue virus envelope protein: A computational approach Comput Biol Chem. 2017 Dec;71:152-160.
- Jitoboam K, Phaonakrop N, Libsittikul S, Thepparit C, Roytrakul S, Smith DR. Actin Interacts with Dengue Virus 2 and 4 Envelope Proteins PLoS One. 2016 Mar 24;11(3):e0151951.
